Related Experiment Video
Updated: Feb 22, 2026

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
Sung Hyun Lee1, Xian Wang2, Sun Hye Kim3
1Department of Molecular Biomedical Sciences, The Center for Human Health and The Environment and The Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Abstract:
Rearrangement and amplification of the D-type cyclin genes have been reported in human cancer. Previous studies have demonstrated that Ras-mediated skin tumorigenesis depends on pathways that act through cyclin D1 and D2; however, the role of cyclin D3 remains unknown. The present study demonstrates that cyclin D3 ablation does not affect keratinocyte proliferation, but instead increases apoptosis levels in the bulge region of the hair follicle. Consequently, cyclin D3 ablation reduces skin papilloma development in a Ras-dependent carcinogenesis model. Previous results revealed that cyclin D3 preferentially binds to cyclin-dependent kinase 6 (CDK6) in mouse keratinocytes and transgenic expression of CDK6 (K5CDK6 mice) inhibits skin tumor development. Thus, we hypothesized that the inhibitory effect of CDK6 is dependent on cyclin D3 expression. To test this hypothesis, a mouse model that overexpresses CDK6 and does not express cyclin D3 (K5CDK6/cyclin D3-/- compound mouse) was developed. Biochemical analysis of the epidermis of K5CDK6/cyclin D3-/- mice revealed that cyclin D3 ablation resulted in increased expression of cyclin D1 protein, with a consequent elevation in the level of CDK6/cyclin D1 and CDK4/cyclin D1 complexes. These findings were concurrent with the increase skin papilloma malignant progression observed in K5CDK6/cyclin D3-/- mice. In summary the absence of cyclin D3 led to fewer number of papillomas in cyclin D3-ablated mice than in the wild-type owing to increased apoptosis, suggesting that alterations in cell survival are a crucial mechanism for crippling cellular defense against neoplasia. The results of the current study also suggest that although cyclin D3 expression does not alter the tumor suppressive role of CDK6 in skin carcinogenesis, the compensatory increase in cyclin D1 can shift the balance towards malignant progression.
Insights
Cyclin D3 deficiency in mice increases apoptosis and reduces skin tumors. However, its absence can lead to increased cyclin D1, promoting malignant progression in a CDK6-overexpressing model.
Area of Science:
- Oncology
- Cell Biology
- Dermatology
Background:
- D-type cyclins are implicated in human cancers.
- Ras-mediated skin tumorigenesis involves cyclin D1 and D2, but cyclin D3's role is unclear.
Purpose of the Study:
- To investigate the role of cyclin D3 in skin carcinogenesis.
- To determine if the tumor-suppressive effect of CDK6 is dependent on cyclin D3.
Main Methods:
- Generated and analyzed a K5CDK6/cyclin D3-/- mouse model.
- Assessed keratinocyte proliferation, apoptosis, and skin papilloma development.
- Performed biochemical analysis of epidermal protein expression and complex formation.
Main Results:
- Cyclin D3 ablation increased apoptosis in hair follicle bulge cells, reducing papilloma formation.
- In K5CDK6/cyclin D3-/- mice, cyclin D3 absence led to increased cyclin D1 expression.
- This compensatory cyclin D1 increase promoted malignant progression of skin papillomas.
Conclusions:
- Cyclin D3 absence enhances apoptosis, acting as a defense against skin neoplasia.
- While CDK6's tumor-suppressive role in skin is not altered by cyclin D3 absence, compensatory cyclin D1 upregulation can drive malignant progression.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Positive Regulator Molecules
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

